ISSN 2412-4036 (print)
ISSN 2713-1823 (online)

Analysis of changes in laboratory indexes in case of severe coronavirus infection among patients of different ages

Vertkin A.L., Kebina A.L., Solodov A.A., Levchenko O.V., Yanushevich O.O.

Russian University of Medicine of the Ministry of Healthcare of Russia, Moscow
Abstract. Since the end of 2019, coronavirus infection caused by SARS-CoV-2 has resulted in over 777 million clinical cases worldwide and over 6.8 million deaths. This virus had the greatest danger to people over 65 and patients with chronic diseases. For today, data on laboratory indexes’ dynamics in COVID-19 patients has been accumulated, but age-specific patterns of these changes have not been studied.
The aim: to study the differences in laboratory parameters in patients with severe coronavirus infection across age groups.
Material and methods. A retrospective, comparative study of laboratory parameters in patients with severe coronavirus infection was performed from 2021 to 2025 at COVID-19 Clinical Center of A.I. Yevdokimov Moscow State Medical University (now Russian University of Medicine) of the Ministry of Healthcare of Russia. The sample consisted of 795 patients (53.6% female and 46.4% male individuals) aged 20 to 90 years (median 70 [61; 80] years), divided into age groups according to WHO criteria. Then a pairwise intergroup analysis of laboratory parameters was performed.
Results. In patients aged 18–44 years, an increase in the median alanine aminotransferase level to 80.75 [41.55; 198.45] U/L was recorded on days 5–7 of hospitalization. Patients aged 60–74 years at the same hospitalization stage were prone to hypoproteinemia, with a median total protein level of 58 [53.2; 62.075] g/L. Patients over 75 years of age were characterized by significant changes in renal function parameters at all stages of hospitalization. The identified changes in these groups can be explained by both the influence of SARS-CoV-2 at organ systems and also the presence of comorbid pathology with its decompensation, which is confirmed by laboratory test results in patients over 75 years of age.
Conclusion. Increasing of the patients’ age is associated with deterioration in protein metabolism, renal function, coagulation disorders, and the development of a “cytokine storm”. Patients over 75 years of age are more likely to have significant laboratory abnormalities indicating a poor prognosis. These obtained data should be considered during outpatient monitoring of individuals who have had severe COVID-19 infection.

Keywords

COVID-19
comparison of patient age groups
comorbidity
hypoproteinemia
renal injury

References

1. World Health Organization. COVID-19 cases, world. https://data.who.int/dashboards/covid19/cases (date of access – 18.11.2025).

2. Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Минздрав России. Версия 18 (26.10.2023). Доступ: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/064/610/original/BMP_COVID-19_V18.pdf (дата обращения – 18.11.2025). (Interim guidelines. Prevention, diagnosis, and treatment of novel coronavirus infection (COVID-19). Ministry of Healthcare of Russia. Version 18 (October 26, 2023). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/064/610/original/BMP_COVID-19_V18.pdf (date of access – 18.11.2025) (In Russ.)).

3. Terpos E, Ntanasis-Stathopoulos I, Elalamy I, Kastritis E, Sergentanis TN, Politou M et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020;95(7):834–47.

PMID: 32282949. PMCID: PMC7262337. https://doi.org/10.1002/ajh.25829

4. Хайтович А.Б., Ермачкова П.А. Патогенез COVID-19. Таврический медико-биологический вестник. 2020;23(4):113–132. (Khaitovich AB, Yermachkova PA. Pathogenesis of COVID-19. Tavricheskiy mediko-biologicheskiy vestnik = Taurida Medical and Biological Bulletin. 2020;23(4):113–132 (In Russ.)).

EDN: PISPZG. https://doi.org/10.37279/2070-8092-2020-23-4-113-132

5. Хамитов Р.Ф., Молоствова А.Ф., Салимова Л.М. Тромбоцитопении и другие проявления коагулопатии: возможности диагностики и лечения при новой коронавирусной инфекции СOVID-19. Вестник современной клинической медицины. 2021;14(3):76–83. (Khamitov RF, Molostvova AF, Salimova LM. Thromboсytopenia and other manifestations of coagulopathy:diagnostic and treatment options for СOVID-19 new сoronavirus infection. Vestnik sovremennoy klinicheskoy meditsiny = The Bulletin of Contemporary Clinical Medicine. 2021;14(3):76–83 (In Russ.)).

EDN: FOPFGE. https://doi.org/10.20969/VSKM.2021.14(3).76-83

6. Патологическая анатомия COVID-19. Атлас. Под ред. Зайратьянца О.В. М.: ГБУЗ «Научно-исследовательский институт организации здравоохранения и медицинского менеджмента Департамента здравоохранения города Москвы». 2020; 140 с. (Pathological anatomy of COVID-19. Atlas. Ed. by Zairatyants OV. Moscow: Research Institute for Healthcare Organization and Medical Management of the Department of Healthcare of Moscow. 2020; 140 pp. (In Russ.)).

EDN: HKZCXM. ISBN: 978-5-907251-57-1.

7. Молочков А.В., Каратеев Д.Е., Огнева Е.Ю., Зулькарнаев А.Б., Лучихина Е.Л., Макарова И.В., Семенов Д.Ю. Коморбидные заболевания и прогнозирование исхода COVID-19: результаты наблюдения 13 585 больных, находившихся на стационарном лечении в больницах Московской области. Альманах клинической медицины. 2020;48(S1):1–10. (Molochkov AV, Karateev DE, Ogneva EYu, Zulkarnaev AB, Luchikhina EL, Makarova IV, Semenov DYu. Comorbidities and predicting the outcome of COVID-19: The treatment results of 13,585 patients hospitalized in the Moscow region. Al’manakh klinicheskoy meditsiny = Almanac of Clinical Medicine. 2020;48(S1):1–10 (In Russ.)).

EDN: PWRQRE. https://doi.org/10.18786/2072-0505-2020-48-040

8. Кебина А.Л., Сычева А.С., Верткин А.Л., Зайратьянц О.В., Погонин А.В., Куандыкова М.В. с соавт. Клинико-анатомический портрет больных с тяжелым течением инфекции COVID-19. Лечащий врач. 2020;(10):15–19 (Kebina AL, Sycheva AS, Vertkin AL, Zairatyants OV, Pogonin AV, Kuandykova MV et al. Clinical and anatomical portrait of patients with severe COVID-19 infection. Lechashchiy vrach = Attending Physician. 2020;(10):15–19 (In Russ.)).

EDN: JTMHXA. https://doi.org/10.26295/OS.2020.60.78.003

9. Выхристенко Л.Р., Счастливенко А.И., Бондарева Л.И., Сидоренко Е.В., Музыка О.Г. Поражение почек при инфекции COVID- 19. Вестник Витебского государственного медицинского университета. 2021;20(1):7–23. (Vykhrystsenko LR, Schastlivenko AI, Bondarava LI, Sidarenko AV, Muzyka OG. Kidney damage in COVID-19 infection. Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta = Vitebsk Medical Journal. 2021;20(1):7–23 (In Russ.)).

EDN: WDUCQC. https://doi.org/10.22263/2312-4156.2021.1.7

10. Батюшин М.М., Трубникова М.А., Тарловская Е.И., Арутюнов Г.П., Батлук Т.И., Башкинов Р.А. с соавт. Влияние поражения почек на течение и прогноз при инфекции COVID-19 по данным международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-COV-2». Архивъ внутренней медицины. 2023;13(2):116–128. (Batiushin MM, Trubnikova MA, Tarlovskaya EI, Arutyunov GP, Batluk TI, Bashkinov RA et al. Impact of kidney damage on the course and prognosis of COVID-19 infection according to the International Registry “Analysis of chronic non-infectious diseases dynamics after Covid-19 infection in adult patients”. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2023;13(2):116–128 (In Russ.)).

EDN: OUIMWB. https://doi.org/10.20514/2226-6704-2023-13-2-116-128

11. Винокуров А.С., Никифорова М.В., Оганесян А.А., Винокурова О.О., Юдин А.Л., Юматова Е.А. COVID-19. Поражение печени – особенности визуализации и возможные причины. Медицинская визуализация. 2020;24(3):26–36. (Vinokurov AS, Nikiforova MV, Oganesyan AA, Vinokurova OO, Yudin AL, Yumatova EA. COVID-19. Liver damage – visualization features and possible causes. Meditsinskaya vizualizatsiya = Medical Visualization. 2020;24(3):26–36 (In Russ.)).

EDN: MMGNON. https://doi.org/10.24835/1607-0763-2020-3-26-36

12. Чамсутдинов Н.У., Абдулманапова Д.Н., Сейдалиева К.Л., Шахбанова М.Ш., Саидова З.Р. Влияние COVID-19 и различных подходов к его лечению на функциональную способность печени. Медицина. Социология. Философия. Прикладные исследования. 2023;(3):173–178. (Chamsutdinov NU, Abdulmanapova DN, Seydalieva KL, Shakhbanova MS, Saidova ZR. The influence of COVID-19 and various approaches to its treatment on the functional ability of the liver. Meditsina. Sotsiologiya. Filosofiya. Prikladnyye issledovaniya = Medicine. Sociology. Philosophy. Applied research. 2023;(3):173–178 (In Russ.)). EDN: RNMTZK.

13. Калмыкова З.А., Кононенко И.В., Скляник И.А., Шестакова М.В., Мокрышева Н.Г. Гипергликемия и возможные механизмы повреждения β-клеток у пациентов с COVID-19. Сахарный диабет. 2020;23(3):229–234. (Kalmykova ZA, Kononenko IV, Sklyanik IA, Shestakova MV, Mokrysheva NG. Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19. Sakharnyy diabet = Diabetes Mellitus. 2020;23(3):229–234 (In Russ.)).

EDN: DGFTLU. https://doi.org/10.14341/DM12485

14. Сычева А.С., Малявина М.А., Тебуева Л.В., Григорьевский Е.Д., Кебина А.Л., Верткин А.Л. с соавт. Особенности течения коронавирусной инфекции COVID-19 у пациентов с коморбидной патологией. Терапия. 2022;8(6):11–26. (Sycheva AS, Malyavina MA, Tebueva LV, Grigorievsky ED, Kebina AL, Vertkin AL et al. Peculiarities of COVID-19 coronavirus infection course in patients with comorbid pathology. Terapiya = Therapy. 2022;8(6):11–26 (In Russ.)).

EDN: ULFRUB. https://doi.org/10.18565/therapy.2022.6.11-26

15. Алексеева Е.И., Тепаев Р.Ф., Шилькрот И.Ю., Дворяковская Т.М., Сурков А.Г., Криулин И.А. COVID-19-ассоциированный вторичный гемофагоцитарный лимфогистиоцитоз (синдром «цитокинового шторма»). Вестник РАМН. 2021;76(1):51–66. (Alexeeva EI, Tepaev RF, Shilkrot IYu, Dvoryakovskaya TM, Surkov AG, Kriulin IA. COVID-19-induced “cytokine storm” – a unique form of macrophage activation syndrome. Vestnik RAMN = Annals of the Russian Academy of Medical Sciences. 2021;76(1):51–66 (In Russ.)).

EDN: NFDLWC. https://doi.org/10.15690/vramn1410

16. Гришаева А.А., Понежева Ж.Б., Чанышев М.Д., Плоскирева А.А., Маннанова И.А., Алешина Н.И. с соавт. Состояние цитокиновой системы у больных с тяжелой формой COVID-19. Лечащий врач. 2021;(6):48–51. (Grishaeva AA, Ponezheva ZhB, Chanyshev MD, Ploskireva AA, Mannanova IA, Aleshina NI et al. The state of the cytokine system in patients with severe COVID-19. Lechashchiy vrach = Attending Physician. 2021;(6):48–51 (In Russ.)).

EDN: QXGEAQ. https://doi.org/10.51793/OS.2021.24.6.010

17. Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097–100.

PMID: 32227090. PMCID: PMC7184507. https://doi.org/10.1093/cvr/cvaa078

18. Siddiqi HK, Libby P, Ridker PM. COVID-19 – a vascular disease. Trends Cardiovasc Med. 2021;31(1):1–5.

PMID: 33068723. PMCID: PMC7556303. https://doi.org/10.1016/j.tcm.2020.10.005

19. O’Sullivan JM, Gonagle DM, Ward SE, Preston R, O’Donnell JS. Endothelial cells orchestrate COVID-19 coagulopathy. Lancet Haematol. 2020;7(8):e553–e555.

PMID: 32619412. PMCID: PMC7326442. https://doi.org/10.1016/S2352-3026(20)30215-5

20. Верткин А.Л., Авдеев С.Н., Ройтман Е.В., Сучков И.А., Кузнецова И.В., Замятин М.Н. с соавт. Вопросы лечения COVID-19 с позиции коррекции эндотелиопатии и профилактики тромботических осложнений. Согласованная позиция экспертов. Профилактическая медицина. 2021;24(4):45–51. (Vertkin AL, Avdeev SN, Roitman EV, Suchkov IA, Kuznetsova IV, Zamyatin MN et al. Treatment of COVID-19 from the perspective of endotheliopathy correction and prevention of thrombotic complications. The agreed position of the experts. Profilakticheskaya meditsina = Russian Journal of Preventive Medicine. 2021;24(4):45–51 (In Russ.)).

EDN: MYILVR. https://doi.org/10.17116/profmed20212404145

21. Абдурахимов А.Х., Хегай Л.Н., Юсупова Ш.К. COVID-19 и его осложнения. Re-health journal. 2021;(4):61–74. (Abdurakhimov AKh, Khegay LN, Yusupova ShK. COVID-19 and its complications. Re-health journal. 2021;(4):61–74 (In Russ.)).

About the Authors

Arkady L. Vertkin, MD, Dr. Sci. (Medicine), professor, head of the Department of therapy, clinical pharmacology, and emergency medical care of the Faculty of general medicine of N.A. Semashko Scientific and Educational Institute of Clinical Medicine of Russian University of Medicine of the Ministry of Healthcare of Russia. Address: 127006, Moscow, 4 Dolgorukovskaya St.
E-mail: kafedrakf@mail.ru
ORCID: https://orcid.org/0000-0001-8975-8608. Scopus ID: 7005408337. eLibrary SPIN: 9605-9117
Anastasia L. Kebina, MD, assistant at the Department of therapy, clinical pharmacology, and emergency medical care of the Faculty of general medicine of N.A. Semashko Scientific and Educational Institute of Clinical Medicine of Russian University of Medicine of the Ministry of Healthcare of Russia. Address: 127006, Moscow, 4 Dolgorukovskaya St.
E-mail: akebina@list.ru
ORCID: https://orcid.org/0000-0002-7570-9650. Scopus ID: 57278863600. eLibrary SPIN: 1173-3423
Alexander A. Solodov, MD, Dr. Sci. (Medicine), director, head of the Department of anesthesiology, resuscitation and intensive care of N.A. Semashko Research and Educational Institute of Clinical Medicine, Russian University of Medicine of the Ministry of Healthcare of Russia. Address: 127006, Moscow, 4 Dolgorukovskaya St.
E-mail: docsol@mail.ru
ORCID: https://orcid.org/0000-0002-8263-1433. Scopus ID:24478012600. eLibrary SPIN: 6946-8672
Oleg V. Levchenko, MD, Dr. Sci. (Medicine), professor, vice-rector, head of the Department of neurosurgery of the Faculty of general medicine of N.A. Semashko Research and Educational Institute of Clinical Medicine, Russian University of Medicine of the Ministry of Healthcare of Russia. Address: 127006, Moscow, 4 Dolgorukovskaya St.
E-mail: truovl@gmail.com
ORCID: https://orcid.org/0000-0003-0857-9398. Scopus ID: 57209426210. eLibrary SPIN: 7811-8550
Oleg O. Yanushevich, MD, Dr. Sci. (Medicine), professor, academician of RAS, rector, head of the Department of periodontology of A.I. Evdokimov Research and Educational Institute of Dentistry, Russian University of Medicine of the Ministry of Healthcare of Russia. Address: 127006, Moscow, 4 Dolgorukovskaya St.
E-mail: msmsu@msmsu.ru
ORCID: https://orcid.org/0000-0002-4293-8465. Scopus ID: 57131101200. eLibrary SPIN: 1452-1387

Similar Articles